Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)
Close on Nov 17, 2026Market cap $2.13BP/E –Yield –
Alamar Biosciences cash
Cash and short-term investments held at the end of each period.
Alamar Biosciences's cash was $226.59M at Sep 30, 2026. For fiscal 2025 it was $30.00M.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.00M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $226.59M | +375.6% |
| Q2 FY2026 | Jun 30, 2026 | $250.05M | – |
| Q1 FY2026 | Mar 31, 2026 | $64.59M | – |
| Q4 FY2025 | Dec 31, 2025 | $30.00M | – |
| Q3 FY2025 | Sep 30, 2025 | $47.64M | – |
See a number that looks wrong?